U.S., April 19 -- ClinicalTrials.gov registry received information related to the study (NCT06933381) titled 'Vapocoolant Spray to Reduce Pain With Nexplanon Insertion' on March 31.
Brief Summary: The purpose of this study is to assess if Pain Ease vapocoolant spray decreases pain associated with lidocaine injection during Nexplanon insertion procedures.
Study Start Date: May 01
Study Type: INTERVENTIONAL
Condition:
Reducing Pain With Nexplanon Implant Insertion
Intervention:
DEVICE: Vapocoolant spray
Pain Ease will be used per manufacturer instruction, applying the spray for 5 seconds or until the skin turns white, whichever occurs first.
OTHER: Placebo
Nature's Tears will be applied to the arm as a placebo spray
Recruitment Sta...